As the development of oligonucleotide-based therapeutics continuities to grow, companies are facing multifaceted challenges in scaling up to meet commercial needs. In this white paper, Ajinomoto Bio-Pharma Services discusses various platforms to easily, quickly, and cost-effectively scale up custom oligonucleotides from research to commercial quantities.

Register today using code AJI for 10% off your conference pass